EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Quality Evaluation Considerations for Stem Cell‐Derived Extracellular Vesicles‐Based Therapeutic Products in China

Tao Na iD, Kehua Zhang, Libo Zhao iD, Xuanbao Yao, Chongfeng Xu, Yuan Zhang, Lan Wang, Miao Xu, Hui Zhang, Shufang Meng

Journal of Extracellular Vesicles · 2026-05 · 15 (5)

DOI: 10.1002/jev2.70297 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 09.05.2026. Verfasst von Tao Na und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institutes for Food and Drug Control, Beijing, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Stem Cells, Stem Cell Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, State Key Laboratory of Drug Regulatory Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stem cell therapy is currently undergoing clinical research in China for conditions that are resistant to or incurable by traditional pharmaceutical interventions. Stem cell‐derived extracellular vesicles (EVs) exhibit therapeutic effects similar to those of their parent stem cells, positioning them as an alternative or adjunctive approach to stem cell therapy. In recent years, given the tremendous potential for EVs in disease treatment, many researchers have focused on the development of stem cell‐derived EVs and have achieved substantial progress in large‐scale production and quality‐related studies. However, at present, there are no specific or targeted regulatory requirements issued by authorities in China regarding the regulation of this novel therapeutic modality or the assurance of its safety and efficacy. In this paper, based on the biological properties of EVs, recent research advances, current understanding of their mechanisms of action, manufacturing processes and quality control strategies, a comprehensive framework for the quality evaluation of stem cell‐derived EV‐based therapeutic products is proposed. This framework is intended to serve as a reference for researchers and developers and may help to facilitate further discussion to facilitate further discussion, thereby supporting and promoting the development, regulatory oversight and establishment of quality standards and evaluation systems for stem cell‐derived EVs in China.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesStem CellsStem Cell TransplantationHumansChinaQuality ControlAnimals

Autor:innen und Institutionen

  • National Institutes for Food and Drug Control, Beijing, China.
  • State Key Laboratory of Drug Regulatory Science, Beijing, China.
  • Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, Beijing, China.
  • Beijing Key Laboratory of Quality Control and Non-Clinical Research and Evaluation for Cellular and Gene Therapy Medicinal Products, Beijing, China.
  • Echo Biotech Co., Ltd., Beijing, China.
  • Center for Drug Reevaluation (National Center for ADR Monitoring), NMPA, Beijing, China.

ORCID-Profile: Tao Na, Libo Zhao

Förderung

  • National Key Research and Development Program of China
  • State Key Laboratory of Drug Regulatory Science

Zitieren

APA

Na, T., Zhang, K., Zhao, L., Yao, X., Xu, C., Zhang, Y., Wang, L., Xu, M., Zhang, H., & Meng, S. (2026). Quality Evaluation Considerations for Stem Cell‐Derived Extracellular Vesicles‐Based Therapeutic Products in China. Journal of Extracellular Vesicles, 15(5). https://doi.org/10.1002/jev2.70297

Vancouver

Na T, Zhang K, Zhao L, Yao X, Xu C, Zhang Y, et al. Quality Evaluation Considerations for Stem Cell‐Derived Extracellular Vesicles‐Based Therapeutic Products in China. Journal of Extracellular Vesicles. 2026;15(5). doi:10.1002/jev2.70297

BibTeX
@article{Na2026,
  author = {Na, Tao and Zhang, Kehua and Zhao, Libo and Yao, Xuanbao and Xu, Chongfeng and Zhang, Yuan and Wang, Lan and Xu, Miao and Zhang, Hui and Meng, Shufang},
  title = {Quality Evaluation Considerations for Stem Cell‐Derived Extracellular Vesicles‐Based Therapeutic Products in China},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/jev2.70297}
}
Kostenlos starten →